Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GAL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | BCL2L15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | GPR6 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
mRNA | WBP1L | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | FBLN5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | RP11-849F2.7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | PCBP4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | TBRG4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | RP11-38C17.1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | ARHGAP20 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |